The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1B study of avelumab and whole brain radiotherapy (WBRT) in patients with leptomeningeal disease (LMD) from epithelial carcinomas: Final results and molecular analyses with single cell RNA sequencing.
 
Yolanda Pina
No Relationships to Disclose
 
Ann Chen
No Relationships to Disclose
 
John Arrington
No Relationships to Disclose
 
Robert J Macaulay
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - BMSi
 
Nam D. Tran
Consulting or Advisory Role - Medtronic
 
James K Liu
No Relationships to Disclose
 
Sepideh Mokhtari
No Relationships to Disclose
 
Jiannong Li
No Relationships to Disclose
 
Vincent Law
No Relationships to Disclose
 
Solmaz Sahebjam
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Boehringer Ingelheim; Merck
Research Funding - Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Pending patent
 
Kamran A. Ahmed
Honoraria - Bristol-Myers Squibb; Cancer Network; Castle Biosciences
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Ben C. Creelan
Honoraria - Achilles Therapeutics; AstraZeneca; ER Squibb & Sons, LLC; Instil BIO; Roche
Speakers' Bureau - AstraZeneca; Novartis
Research Funding - Cancer Research Institute (Inst); Clinigen Group; E. R. Squibb & Sons, LLC (Inst)
Patents, Royalties, Other Intellectual Property - Patent WO2020263919A1 pending; Patent WO2021163695A2 pending
Travel, Accommodations, Expenses - AstraZeneca
 
Jhanelle Elaine Gray
Honoraria - Jazz Pharmaceuticals; Merck; OncoCyte
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca/MedImmune; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Bristol Myers Squibb; EMD Serono; Janssen Scientific Affairs; Jazz Pharmaceuticals; Lilly; Loxo; Merck Sharp & Dohme; National Comprehensive Cancer Network; Novartis; Sanofi
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); ECOG-ACRIN (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Ludwig Institute for Cancer Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); SWOG (Inst)
Travel, Accommodations, Expenses - Novartis; OncoCyte
 
Brittany Evernden
No Relationships to Disclose
 
Nikhil I. Khushalani
Stock and Other Ownership Interests - Amarin Corporation; Asensus Surgical; Bellicum Pharmaceuticals
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Castle Biosciences; Genzyme; Immunocore; Incyte; Instil Bio; Iovance Biotherapeutics; Jounce Therapeutics; Merck; NCCN/Pfizer; Nektar; Novartis; Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); Merck (Inst); Modulation Therapeutics (Inst); Novartis (Inst); Regeneron (Inst); Replimune (Inst)
Other Relationship - Bristol-Myers Squibb/Celgene; Nektar; Regeneron; Replimune
 
Inna Smalley
Consulting or Advisory Role - LEK
Research Funding - Revolution Medicines (I)
Patents, Royalties, Other Intellectual Property - I have a patent pending related to the diagnostics of leptomeningeal disease. I am the inventor but I believe my institution holds the intellectual property rights (Inst)
 
Michael A. Vogelbaum
Stock and Other Ownership Interests - Infusion Therapeutics
Honoraria - Chimerix; Plus Therapeutics
Consulting or Advisory Role - Midatech Pharma; Olympus
Research Funding - Celgene (Inst); Denovo Biopharma (Inst); Infusion Therapeutics (Inst); Oncosynergy (Inst)
Patents, Royalties, Other Intellectual Property - Patents for drug delivery devices for the brain
 
Michael Yu
Research Funding - Pfizer (Inst)
 
Keiran Smalley
Research Funding - Revolution Medicines (Inst)
 
Peter A. J. Forsyth
Honoraria - Abbvie; BTG; Novocure; Stanford University Health, Department of Neurology
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; BTG; Midatech Pharma; National Brain Tumor Society; Novartis; Novocure; Tocagen; ZIOPHARM Oncology
Research Funding - Bankhead-Coley Cancer Research; Bristol-Myers Squibb; Department of Defense; Florida Academic Cancer Center Alliance; Florida Breast Cancer Foundation; MSCCoE; NIH/NCI; Pfizer
Travel, Accommodations, Expenses - Abbvie; Bayer; Bristol-Myers Squibb; BTG; Inovio Pharmaceuticals; National Cancer Research Institute (NCRI); NCCN; NCI; NIH; Physical Sciences Oncology Network